ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference

Rhea-AI Summary

ENDRA Life Sciences (NASDAQ: NDRA), a leader in enhanced ultrasound technology, will present at the JMP Securities Life Sciences Conference in New York City on June 15-16, 2022. The company's overview is scheduled for June 15 at 2:30 PM Eastern time, with additional one-on-one investor meetings available. ENDRA's innovative TAEUS® technology offers MRI-like tissue visualization at 1/50th the cost. Initially targeting Non-Alcoholic Fatty Liver Disease, it has broader applications, including tissue temperature monitoring during surgical procedures.

ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that management will be participating in the JMP Securities Life Sciences Conference being held June 15-16, 2022 in New York City. Management will present a company overview on Wednesday, June 15^th at 2:30 p.m. Eastern time and will host one-on-one meetings with investors. To request a meeting, please contact JMP Securities or Yvonne Briggs of LHA at ybriggs@lhai.com.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS^®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50^th the cost and at the point of patient care. TAEUS^® is designed to work in concert with over 500,000 ultrasound systems in use globally today. TAEUS^® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS^®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220608005192/en/

Irina Pestrikova

Senior Director, Finance

investors@endrainc.com

www.endrainc.com

Investor Relations:

Yvonne Briggs

LHA Investor Relations

(310) 691-7100

YBriggs@lhai.com

Source: ENDRA Life Sciences Inc.

FAQ

When is ENDRA Life Sciences presenting at the JMP Securities Life Sciences Conference?

ENDRA Life Sciences will present on June 15, 2022, at 2:30 PM Eastern time.

What technology does ENDRA Life Sciences focus on?

ENDRA Life Sciences focuses on TAEUS®, which visualizes tissue like MRI at a significantly lower cost.

What are the initial applications of ENDRA's TAEUS® technology?

The initial application is the measurement of fat in the liver to assess Non-Alcoholic Fatty Liver Disease.

How does TAEUS® compare to traditional imaging methods?

TAEUS® provides MRI-like imaging at 1/50th the cost and works with existing ultrasound systems.

Who should I contact for a meeting with ENDRA Life Sciences management?

To request a meeting, contact JMP Securities or Yvonne Briggs at LHA via email.